WE HAVE A CHOICE TO MAKE AS A SOCIETY TO SCREEN FOR MORE CANCERS SO WE CAN TRY TO FIND THEM EARLIER OR CONTINUE TO FACE THE OVERWHELMING BURDEN OF LATE-STAGE CANCER AND DO NOTHING BUT WAIT… The advancement of liquid biopsy assays (LBx) provides an opportunity to...
We kindly remind you that our Annual Congress 2022 will take place from September 14, starting 3 pm to September 16, ending 3 pm at the Royal Netherlands Academy of Arts and Sciences in Amsterdam. In Western countries, it seems that cancer is treated much better than...
Peter: “I know from personal experience just how important stem cell donors are. In 2005 I was diagnosed with a lymphoma and, after three relapses, I needed an unrelated bone marrow transplant. The patient needs a match with a donor on the HLA (Human Leukocyte Antigen...
A paradigm shift in healthcare The repurposing of approved/failed drugs is an attractive and pragmatic approach for rapidly finding new, affordable therapeutics for new indications. Additionally, off-patent drugs, with their enormous patient data from years of usage,...
The third edition of the Dutch National Cancer and Work Day (Nationale Kanker en Werk Dag or NKWD) will take place on March 15 2022, preceded by 2 online introductory sessions on February 10 and 17. This year the organisers will promote job retention and sustainable...
